India has cancelled the manufacturing licence of a agency whose cough syrups have been linked to 18 youngster deaths in Uzbekistan.

The WHO in January had warned in opposition to the usage of two cough syrups made by Marion Biotech, saying they have been substandard.

Marion Biotech denies the allegations.

After the deaths have been reported in Uzbekistan, India’s well being ministry had suspended manufacturing on the firm.

On Wednesday, authorities in Uttar Pradesh state – the place Marion Biotech relies – stated they have been now “permanently” cancelling the corporate’s licence.

The BBC has reached out to state authorities for an announcement.

Marion Biotech has not responded to BBC’s request for remark.

India is the world’s largest exporter of generic medicine, assembly a lot of the medical wants of creating international locations.

But in current months, many Indian companies have come underneath scrutiny for the standard of their medicine, with specialists elevating issues concerning the manufacturing practices used to make these medicines.

The newest motion in opposition to Marion Biotech got here after exams by a authorities laboratory in December discovered 22 drug samples of the agency’s cough syrup to be “adulterated and spurious”.

“The adulterated and spurious drugs can cause grievous hurt to the public and it is suspected that related material/records may be disposed of,” Asheesh Kaundal, inspector of India’s Central Drugs Standard Control Organisation (CDSCO), had said in his complaint.

Earlier this month, the Uttar Pradesh police had additionally arrested three staff of the corporate for promoting adulterated merchandise.

On Wednesday, SK Chaurasia, the Drugs Licensing Officer of Uttar Pradesh, stated that Marion Biotech had failed to answer the discover issued to them in reference to the findings “satisfactorily”.

India launched an investigation in opposition to Marion Biotech after the WHO issued a worldwide medical alert, linking the deaths of 18 kids in Uzbekistan to the agency’s Dok-1 Max and Ambronol cough syrups.

The well being physique stated an evaluation by the standard management laboratories of Uzbekistan’s well being ministry had discovered “unacceptable amounts” of Diethylene glycol and ethylene glycol within the medicine.

The substances are poisonous to people and might be deadly if consumed.

In an emailed response to the BBC in January, Marion Biotech stated that it “did not agree” with the WHO’s findings and that it was cooperating with investigations being carried on by the Indian authorities.

Marion Biotech is not the primary Indian drug maker to get into bother over its cough syrups.

In October, WHO had sounded a global alert and linked 4 cough syrups made by Maiden Pharmaceuticals to the deaths of 66 kids from kidney accidents in The Gambia..

Both the Indian authorities and the corporate, Maiden Pharmaceuticals, have denied the allegations.

BBC News India is now on YouTube. Click to subscribe and watch our documentaries, explainers and options.